TNBC is a subtype of BC with negative estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor–2 (HER–2) [2], accounting for 15–20% of all diagnosed BC, and has the characteristics of strong invasiveness, rapid distant metastasis, and short survival time [3]. Here, ESR1 is linked to breast cancer.